FDA Warns CBD Companies About Medicinal Claims

Although plenty of businesspeople in the cannabis community regard various properties of the plant as effective medicine for a number of ailments, the U.S. Food and Drug Administration doesn’t necessarily agree.

The agency recently sent six strictly worded warning letters to companies across the country that peddle CBD-based products, telling all that they need to quit making medicinal claims or face legal action.

“Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are ‘new drugs,'” the FDA wrote to CBD Life Holdings in Arizona. “New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA…You should take prompt action to correct the violations cited in this letter.”

Similar letters were sent to Hemp Oil Care in California, Twin Falls Bio Tech in South Carolina, and three Washington State companies: Purecbd.net, Canna Pet, and Canna Companion.

The companies were all warned to take action to rectify problems the FDA identified within 15 working days of receiving the letters.

Daily News | Briefs | Legal & Regulatory News for Marijuana Businesses


  1. and another thing... March 7, 2015
  2. Joel March 7, 2015
  3. Angela March 7, 2015
  4. Angela March 7, 2015
  5. Gentle jim March 8, 2015
  6. Bill Ziese March 9, 2015
  7. Jay Matts March 13, 2015

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.